Is FIB-4 the right tool for screening for liver fibrosis? Leen JM. Heyens; Demi P.A.van Malde; Gediz Dogay Us; Francesco Innocenti; Mathieu Struyve; Christophe Van Steenkiste; Sven Francque; Geert Robaeys; Ger H. Koek;

New FIB-4 and NFS cutoffs to guide sequential non-invasive assessment of liver fibrosis by magnetic resonance elastography in NAFLD Louise Torres; Alice Schuch; Larisse Longo; Bruna Bressan Valentini; Gabriela Schneider Galvão; Eduardo Luchese; Carlos Pinzon; Rodrigo Bartels; Mário Reis Álvares-da-Silva;

Alpha-1 antitrypsin Pi*MZ variant increases the risk of liver disease progression in MASLD and MASH Bradley Jermy; Jack Brownrigg; Pavel Strnad; Rohit Loomba;